NexImmune, Inc.
NEXIDelisted Sep 6, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001538210
NexImmune, Inc. was delisted on Sep 6, 2024; its insiders filed their last Form 4 on Jun 13, 2024; 13 institutions reported holding it in 13F filings for Q2 2024, worth $408.6K in total; no superinvestor held it.
Q2 2021 vs. Q1 2021
How the institutions holding NexImmune, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 46 | 42 | −4 |
| Shares | 9.69M | 9.71M | +15.2K (+0.2%) |
| Value | $184.9M | $119.0M | −$65.9M (−35.7%) |
New holders (2)
Institutions that held NexImmune, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Russell Investments Group, Ltd. | 2,432 | $39.0K | 0.00% |
| State of Wyoming | 771 | $13.0K | 0.01% |
Sold out (6)
Institutions that held NexImmune, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| HBK Investments L P | 30,000 | $572.0K |
| Hudson Bay Capital Management LP | 25,000 | $477.0K |
| Maven Securities LTD | 25,000 | $461.0K |
| Marshall Wace North America L.P. | 24,001 | $458.0K |
| Jane Street Group, LLC | 13,226 | $252.0K |
| Bank of Montreal | 236 | $4.00K |